Physician profile
Jonathan Patrick Gaspar
NPI 1174744429
$10,453.27
in general payments reported to CMS, 2019-2025
42 companies · $1,977 in 2025
The $1,977 reported for 2025 was more than what 79% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $551 · 2021: $1,025 · 2022: $1,705 · 2023: $1,763 · 2024: $2,448 · 2025: $1,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,187.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,068.46 | 2019-2025 | |
| Janssen Biotech, INC. | $1,128.23 | 2019-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $860.63 | 2019-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $794.21 | 2019-2025 | Xifaxan, Trulance |
| Genzyme Corporation | $472.39 | 2022-2025 | |
| Pfizer INC. | $394.32 | 2019-2025 | |
| Celgene Corporation | $346.61 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $241.28 | 2019-2025 | Sucraid |
| Boston Scientific Corporation | $232.43 | 2024-2025 | Axios, Wallflex Duodenal |
| Ardelyx, INC. | $220.59 | 2022-2025 | Ibsrela |
| Conmed Corporation | $142.78 | 2024 | Conmed Generators, Conmed Biliary, Conmed Hemostasis |
| Gilead Sciences, INC. | $127.17 | 2019-2022 | |
| Phathom Pharmaceuticals, INC. | $109.25 | 2024 | Voquezna |
| Nestle Healthcare Nutrition INC. | $94.66 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $90.06 | 2022-2024 | Rebyota |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Gaspar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.